Control of Hepatitis A by Universal Vaccination of Adolescents, Puglia, Italy
نویسندگان
چکیده
documented evidence about the use of the specifi c milk replacers, we conservatively assumed that 12 of 13 case farms used the specifi c milk replacers. We estimated the odds ratio for this risk factor by using logistic regression analysis. Our results indicated that the use of the milk replacers produced by the specifi c factory was associated with BSE infection (odds ratio [OR] 39.3, 95% confi dence interval [CI] 4.9–312.9, p = 0.0005). The milk replacers produced by the specifi c factory contained tallow that was produced at domestic rendering factories and imported from the Netherlands. Milk replacers were fed to calves during a relatively short period after birth (an average of 79 and 68 days, for case and control farms, respectively). If 1 production lot of milk replacer became accidentally contaminated with BSE, the exposure would occur in newborn calves within a relatively short period. This contamination may explain why 11 of 13 BSE-infected calves were born within a 2-month period from February 10, 1996, to April 8, 1996. In Hokkaido, 9 of 10 BSE-infected calves were fed calf concentrates produced in the same feed factory. This proportion was higher than that of the 50 control farms in Hokkaido (22/50, Fisher exact test, p = 0.013). The calf concentrates might have become contaminated with meat-andbone meal (MBM) because this factory used MBM for other animal feed. Multivariate logistic regression analysis, including this factor and that for the specifi c milk replacers, did not indicate signifi cant association between the specifi c calf concentrates and occurrence of BSE (calf concentrates: OR 3.2 [CI 0.8–13.0], p = 0.14; milk replacers: OR 21.7 [CI 2.5–192.6], p = 0.006). The factory that provided the specifi c concentrates belonged to a company affi liated with the company that produced the milk replacers in question. Given the fact that farmers tend to use milk replacers and calf concentrates from the same company, association of the calf concentrates with the BSE infection may have been masked by the use of specifi c milk replacers. However, our study is limited by the small number of BSE cases and investigation of events that occurred 10 years ago. A possible causal association between the feeding of potentially contaminated milk replacers to calves and the occurrence of BSE has been suggested by several epidemiologic studies (2–5). However, no report shows experimental transmission of BSE by use of tallow or milk replacers (6). This lack of evidence in the literature may suggest that the risk of contracting BSE from processed tallow or milk replacers is low (7). If MBM is excluded as a source of infection, other transmission mechanisms, such as the feeding of animal fat, may become more important.
منابع مشابه
Hepatitis A in Puglia (South Italy) after 10 years of universal vaccination: need for strict monitoring and catch-up vaccination
BACKGROUND Raw seafood consumption was identified as the major risk factor for hepatitis A during the large epidemic of 1996 and 1997 in Puglia (South Italy). In Puglia, vaccination for toddlers and preadolescents has been recommended since 1998.The aim of the study was to evaluate the incidence, seroprevalence, molecular epidemiology, and environmental circulation of hepatitis A virus (HAV) in...
متن کاملEffect of the Apulia air quality plan on PM10 and benzo(a)pyrene exceedances
During the last years, several exceedances of PM10 and benzo(a)pyrene limit values exceedances were recorded in Taranto, a city in southern Italy included in so-called areas at high risk of environmental crisis because of the presence of a heavy industrial district including the largest steel factory in Europe. A study of these critical pollution events showed a close...
متن کاملTwenty Years of Universal Vaccination Against Hepatitis B in Italy: Achievements and Challenges
UNLABELLED Viral hepatitis B is a vaccine-preventable disease. Vaccination has proved to be safe and highly effective in reducing the incidence, the carrier rate and HBV-related mortality on a global scale. In Italy, universal vaccination against hepatitis B started in 1991 in infants as well as in adolescents, providing an outstanding record of safety and effectiveness. Within a few years, ove...
متن کاملهپاتیت ویروسی و پیشگیری از آن وضعیت موجود با نگاهی به آینده
Viral hepatitis is the most common cause of liver disease in the world. In the past 30 years, highly effective vaccines have become available for two of the five hepatitis viruses, and where implemented, vaccination has become a key component of hepatitis prevention. To provide a current review and critical analysis of the viral hepatitis, A (HAV) and B (HBV) prevention by immunization has be...
متن کاملPersistence of immunity to hepatitis B vaccine as infants, 17 years earlier
Background: In Iran scince 1992, hepatitis B vaccination was a part of the national vaccination program. Hepatitis B vaccination is effective in the epidemiology of hepatitis B. The aim ofthis study was to evaluate the long – term persistence of immunity. Methods: This cross-sectional analytical study was conducted on children and adolescents aged between 6-18 years in Birjand, who recei...
متن کاملPii: S0264-410x(02)00580-7
10 Ten years have elapsed since routine vaccination of infants and of 12-year-old adolescent was implemented in Italy. 11 In this period, evidence has accumulated on the epidemiological impact of universal immunisation. 12 Coverage is on average >90% and is ≥95% in many areas of the country. Incidence of acute hepatitis B, that was already declining before 1991, was further decreased by routine...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Emerging Infectious Diseases
دوره 14 شماره
صفحات -
تاریخ انتشار 2008